Follow
Arutha Kulasinghe
Arutha Kulasinghe
NHMRC Research Fellow, Clinical-oMx Lab Head, University of Queensland
Verified email at uq.edu.au - Homepage
Title
Cited by
Cited by
Year
Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel
J Zhou, A Kulasinghe, A Bogseth, K O’Byrne, C Punyadeera, I Papautsky
Microsystems & nanoengineering 5 (1), 1-12, 2019
1282019
Circulating biomarkers in patients with glioblastoma
J Müller Bark, A Kulasinghe, B Chua, BW Day, C Punyadeera
British journal of cancer 122 (3), 295-305, 2020
1152020
Circulating tumour cells in metastatic head and neck cancers
A Kulasinghe, C Perry, L Jovanovic, C Nelson, C Punyadeera
International journal of cancer 136 (11), 2515-2523, 2015
962015
The prognostic role of circulating tumor cells (CTCs) in lung cancer
J Kapeleris, A Kulasinghe, ME Warkiani, I Vela, L Kenny, K O'Byrne, ...
Frontiers in oncology 8, 311, 2018
932018
The prognostic significance of circulating tumor cells in head and neck and non‐small‐cell lung cancer
A Kulasinghe, J Kapeleris, R Kimberley, SR Mattarollo, EW Thompson, ...
Cancer medicine 7 (12), 5910-5919, 2018
832018
Capture of circulating tumour cell clusters using straight microfluidic chips
A Kulasinghe, J Zhou, L Kenny, I Papautsky, C Punyadeera
Cancers 11 (1), 89, 2019
692019
Enrichment of circulating head and neck tumour cells using spiral microfluidic technology
A Kulasinghe, THP Tran, T Blick, K O’Byrne, EW Thompson, ME Warkiani, ...
Scientific Reports 7 (1), 1-10, 2017
672017
PD-L1 expressing circulating tumour cells in head and neck cancers
A Kulasinghe, C Perry, L Kenny, ME Warkiani, C Nelson, C Punyadeera
BMC Cancer 17 (333), 2017
562017
A collective route to head and neck cancer metastasis
A Kulasinghe, H Schmidt, C Perry, B Whitfield, L Kenny, C Nelson, ...
Scientific reports 8 (1), 1-8, 2018
492018
Short term ex-vivo expansion of circulating head and neck tumour cells
A Kulasinghe, C Perry, ME Warkiani, T Blick, A Davies, K O'Byrne, ...
Oncotarget 7 (37), 60101, 2016
492016
Understanding the tumor microenvironment for effective immunotherapy
H Sadeghi Rad, J Monkman, ME Warkiani, R Ladwa, K O'Byrne, N Rezaei, ...
Medicinal Research Reviews 41 (3), 1474-1498, 2021
442021
A liquid biopsy for head and neck cancers
H Schmidt, A Kulasinghe, C Perry, C Nelson, C Punyadeera
Expert review of molecular diagnostics 16 (2), 165-172, 2016
412016
The use of microfluidic technology for cancer applications and liquid biopsy
A Kulasinghe, H Wu, C Punyadeera, ME Warkiani
Micromachines 9 (8), 397, 2018
402018
The development of a liquid biopsy for head and neck cancers
H Schmidt, A Kulasinghe, L Kenny, C Punyadeera
Oral oncology 61, 8-11, 2016
402016
Impact of label-free technologies in head and neck cancer circulating tumour cells
A Kulasinghe, L Kenny, C Perry, JP Thiery, L Jovanovic, I Vela, C Nelson, ...
Oncotarget 7 (44), 71223, 2016
382016
Advances in salivary diagnostics
CF Streckfus
Springer, 2015
322015
Endothelial cells are not productively infected by SARS‐CoV‐2
L Schimmel, KY Chew, CJ Stocks, TE Yordanov, P Essebier, ...
Clinical & translational immunology 10 (10), e1350, 2021
292021
Emerging Standards and the Hybrid Model for Organizing Scientific Events During and After The COVID-19 Pandemic
S Hanaei, A Takian, R Majdzadeh, CR Maboloc, I Grossmann, O Gomes, ...
Disaster medicine and public health preparedness, 1-17, 2020
292020
Phenotypic characterization of circulating lung cancer cells for clinically actionable targets
A Kulasinghe, J Kapeleris, C Cooper, ME Warkiani, K O’Byrne, ...
Cancers 11 (3), 380, 2019
282019
Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC)
C O’Leary, H Gasper, KB Sahin, M Tang, A Kulasinghe, MN Adams, ...
Pharmaceuticals 13 (10), 273, 2020
232020
The system can't perform the operation now. Try again later.
Articles 1–20